819 Extragenital Lichen Sclerosus Is an Immune-Related Adverse Event With Nivolumab

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.895
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pericardial Effusion With Tamponade, an Immune-Related Adverse Event Associated With Nivolumab Therapy: A Case Report and Review of the Literature

Journal of Cancer Therapy
2018English

Lichen Sclerosus Et Atrophicus

English

Lichen Sclerosus Et Atrophicus.

BMJ
1987English

Clinical Significance of Immune and Antiendotoxin Homeostasis in Premenopausal Patients With Vulvar Lichen Sclerosus

Rossiiskii vestnik akushera-ginekologa
2015English

Association of Vulvar Melanoma With Lichen Sclerosus

Acta Dermato-Venereologica
DermatologyMedicine
2019English

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association With Outcomes

Clinical Cancer Research
Cancer ResearchOncology
2015English

Lichen Sclerosus and Risk of Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Hämorrhagischer Lichen Sclerosus Et Atrophicus

hautnah dermatologie
2015English

Lichen Sclerosus – Inzidenz Bei Harnröhrenstriktur

Aktuelle Urologie
Urology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy